Histone deacetylase inhibitors butyrate and bufexamac inhibit <i>de novo</i> HIV-1 infection in CD4 T-cells

Lin Chen(Department of Virology), Christian Schölz(Department of Virology)

bioRxiv (Cold Spring Harbor Laboratory)

May 1, 2020

10.1101/2020.04.29.067884

Cited by 0

Related Papers

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

|BMC Cancer|2017|226

Decrypting drug actions and protein modifications by dose- and time-resolved proteomics

|Science|2023|117

Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma

|International Journal of Cancer|2013|46

Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53

|Cell Death and Disease|2018|13

110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)

|Hematological Oncology|2025|0